212 related articles for article (PubMed ID: 21428699)
1. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
Abd-Elbary A; Haider M; Sayed S
Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
[TBL] [Abstract][Full Text] [Related]
2. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
Wang MY; Yang YP; Chang JB; Guo MT
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
[TBL] [Abstract][Full Text] [Related]
3. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
Tadros MI
Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
[TBL] [Abstract][Full Text] [Related]
4. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
5. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
[TBL] [Abstract][Full Text] [Related]
6. A novel system for three-pulse drug release based on "tablets in capsule" device.
Li B; Zhu J; Zheng C; Gong W
Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
Nie SF; Liu H; Liu YL; Pan WS
Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
Mandal S; Ray R; Basu SK; Sa B
J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
[TBL] [Abstract][Full Text] [Related]
9. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
[TBL] [Abstract][Full Text] [Related]
10. Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.
Li L; Sun H; Gao J; Jiang T; Gao Y; Zhang J
Pak J Pharm Sci; 2013 Sep; 26(5):929-37. PubMed ID: 24035948
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
[TBL] [Abstract][Full Text] [Related]
12. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
13. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.
Barzegar-Jalali M; Hanaee J; Omidi Y; Ghanbarzadeh S; Ziaee S; Bairami-Atashgah R; Adibkia K
Drug Res (Stuttg); 2013 Feb; 63(2):60-4. PubMed ID: 23447074
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
Al-Zoubi NM; AlKhatib HS; Obeidat WM
Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372
[TBL] [Abstract][Full Text] [Related]
16. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
17. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
[TBL] [Abstract][Full Text] [Related]
18. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability.
El-Kamel AH; Al-Gohary OM; Hosny EA
J Microencapsul; 2003; 20(2):211-25. PubMed ID: 12554376
[TBL] [Abstract][Full Text] [Related]
19. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
Cui Q; Zhu Y; Cui J
Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]